This Harvard grad is building a luxury weed business that he expects to bring in $50 million a year

  • 📰 CNBC
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 72%

Business News News

Business Business Latest News,Business Business Headlines

This Harvard MBA grad is building a luxury weed business — 'the Hermès of cannabis' — that he expects to bring in $50 million a year. via CNBCMakeIt

Canndescent's Instagram page looks like that of a luxury lifestyle company. It features chic people doing yoga, painting, working out, surfing, partying and reading in the bathtub.Adrian Sedlin, a graduate of Harvard Business School and the founder and CEO of Canndescent, wants to make pot sophisticated.

Cannabis is also still illegal according to federal law. It's part of what stops big companies from investing in the industry. Entrepreneurs, though, like Sedlin, are enamored by the potential. Canndescent sells five varieties of cannabis, with names based on emotional states: Calm, Cruise, Create, Connect and Charge.

If Sedlin is right about the business's potential, he says Canndescent will be selling $52 million worth of weed per year by 2019. In 2016, sales were $228,000, in 2017 they will be $5.1 million and in 2018, Sedlin predicts sales of $17 million. Desert Hot Springs, where Canndescent is based, went bankrupt in 2001 and almost did again in 2014. Then, the town decided to become the first place in California to allow indoor pot farming on an industrial scale. The once impoverished town has experienced a renaissance.

Even as Sedlin and other cannabis entrepreneurs bring money and jobs to their local community, they still have to push against entrenched stereotypes.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

MakeIt This article is from August 2017 . Must be cause your so hi on 4 20 you don’t know .

MakeIt WHEN ASKED IF HE IS THE FIRST HARVARD GRADUATE DRUGDEALERS No, there's plenty of 'em in biotech. Go talk to the guys at Amgen and Pfizer. They're dealing stuff — Percocet — all that highly addictive — Xanax — that stuff will mess up your life. This won't. $FB 🤠 TOO

MakeIt Cool

MakeIt

MakeIt Good luck handling the cash

MakeIt There’s a market for elite budz.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in BUSİNESS

Business Business Latest News, Business Business Headlines